These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33486722)

  • 21. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
    Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
    Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
    Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
    Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2.
    Chiu YL; Wu YY; Barndt RB; Yeo YH; Lin YW; Sytwo HP; Liu HC; Xu Y; Jia B; Wang JK; Johnson MD; Lin CY
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):692-702. PubMed ID: 30777474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The matriptase-prostasin proteolytic cascade in epithelial development and pathology.
    Miller GS; List K
    Cell Tissue Res; 2013 Feb; 351(2):245-53. PubMed ID: 22350849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase.
    Holt-Danborg L; Vodopiutz J; Nonboe AW; De Laffolie J; Skovbjerg S; Wolters VM; Müller T; Hetzer B; Querfurt A; Zimmer KP; Jensen JK; Entenmann A; Heinz-Erian P; Vogel LK; Janecke AR
    Hum Mol Genet; 2019 Mar; 28(5):828-841. PubMed ID: 30445423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.
    Friis S; Uzzun Sales K; Godiksen S; Peters DE; Lin CY; Vogel LK; Bugge TH
    J Biol Chem; 2013 Jun; 288(26):19028-39. PubMed ID: 23673661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women.
    Frederiksen-Møller B; Jørgensen JS; Hansen MR; Krigslund O; Vogel LK; Andersen LB; Jensen BL
    J Hypertens; 2016 Feb; 34(2):298-306. PubMed ID: 26867056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner.
    Su HC; Liang YA; Lai YJ; Chiu YL; Barndt RB; Shiao F; Chang HD; Lu DD; Huang N; Tseng CC; Wang JK; Lee MS; Johnson MD; Huang SM; Lin CY
    PLoS One; 2016; 11(12):e0167894. PubMed ID: 27936035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.
    Friis S; Godiksen S; Bornholdt J; Selzer-Plon J; Rasmussen HB; Bugge TH; Lin CY; Vogel LK
    J Biol Chem; 2011 Feb; 286(7):5793-802. PubMed ID: 21148558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mild acidity likely accelerates the physiological matriptase autoactivation process: a comparative study between spontaneous and acid-induced matriptase zymogen activation.
    Jia B; Thompson HA; Barndt RB; Chiu YL; Lee MJ; Lee SC; Wang JK; Tang HJ; Lin CY; Johnson MD
    Hum Cell; 2020 Oct; 33(4):1068-1080. PubMed ID: 32779152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
    Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
    Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
    J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.
    Szabo R; Lantsman T; Peters DE; Bugge TH
    Development; 2016 Aug; 143(15):2818-28. PubMed ID: 27385010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity and inhibition of prostasin and matriptase on apical and basolateral surfaces of human airway epithelial cells.
    Nimishakavi S; Besprozvannaya M; Raymond WW; Craik CS; Gruenert DC; Caughey GH
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(2):L97-106. PubMed ID: 22582115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The difference in the intracellular Arg/Lys-rich and EHLVY motifs contributes to distinct subcellular distribution of HAI-1 versus HAI-2.
    Huang N; Barndt RB; Lu DD; Wang Q; Huang SM; Wang JK; Chang PY; Chen CY; Hu JM; Su HC; Johnson MD; Lin CY
    Hum Cell; 2022 Jan; 35(1):163-178. PubMed ID: 34643933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matriptase and prostasin are expressed in human skin in an inverse trend over the course of differentiation and are targeted to different regions of the plasma membrane.
    Lai CH; Chang SC; Chen YJ; Wang YJ; Lai YJ; Chang HD; Berens EB; Johnson MD; Wang JK; Lin CY
    Biol Open; 2016 Oct; 5(10):1380-1387. PubMed ID: 27543057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.
    Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.
    Chou FP; Chen YW; Zhao XF; Xu-Monette ZY; Young KH; Gartenhaus RB; Wang JK; Kataoka H; Zuo AH; Barndt RJ; Johnson M; Lin CY
    Am J Pathol; 2013 Oct; 183(4):1306-17. PubMed ID: 24070417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
    Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
    J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
    Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
    Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.